Fanfare Entertainment And Muses Labs Partner To Create Alzheimer’s MEND Protocol App

Fanfare Entertainment And Muses Labs Partner To Create Alzheimer’s MEND Protocol App
Burlingame, California based mobile platform company Fanfare Entertainment has partnered with Muses Labs to help develop, optimize, and market a next-generation personalized combination therapy for treatment and prevention of Alzheimer's disease. The MEND (metabolic enhancement for neurodegeneration) Protocol is designed to enable Alzheimer's disease patients, their caregivers, family members, and doctors to benefit from a set of monitoring, measuring, testing, tracking, motivation, and adherence functions. According to the Alzheimer's Association, Alzheimer's disease is now the sixth leading cause of death in the United States, and the only one of the top 10 causes that can't be prevented, cured or slowed. There are an estimated 5.4 million Alzheimer's patients in the US alone and roughly 75 million people in the US who carry the ApoE4 gene, placing them at significantly higher risk of developing Alzheimer's disease, and who would particularly benefit from pro-active prevention. The MEND Protocol incorporates personalized combination therapy for Alzheimer's disease (AD) that has been shown to slow cognitive decline in patients with early Alzheimer's disease or its precursors, mild cognitive impairment (MCI) or subjective cognitive impairment (SCI). Based on broad understanding of Alzheimer's disease pathogenesis, the MEND Protocol targets multiple interrelated and underlying biological mechanisms of AD simultaneously. The Protocol consists of a complex combination therapy that is personalized for each individual patient, and this personalization process, enabled by technology developed by Muses Labs, is based the individual's genome, blood chemistry, medical history, medications, and other factors. Developed in close collabor
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *